Anne-Marie Duliege, EVP, Chief of Strategic Development at ChemoCentryx, Inc. (CCXI), sold 4,970 shares at $4.71 ($23K) on 2014-11-18, disclosed to the SEC on 2014-11-20.
Scheduled sale ($23k) by EVP, Chief of Strategic Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RIGL | SELL | 2018-07-05 | $14K | — | Filing → |
| RIGL | SELL | 2018-04-24 | $21K | — | Filing → |
| RIGL | SELL | 2017-07-07 | $13K | — | Filing → |